Glutathione in the UAE — research overview of the master antioxidant tripeptide

Glutathione is a tripeptide (γ-glutamyl-cysteinyl-glycine) found in every human cell, where it functions as the body’s primary intracellular antioxidant and a critical substrate for phase-II detoxification. It is the most-discussed antioxidant compound in the UAE wellness market — sold as IV infusions in Dubai longevity clinics, oral capsules, sublingual sprays, liposomal formulations, and skin-brightening protocols. The published research on supplementation efficacy is more nuanced than the marketing narrative.

Structure and biology

Glutathione (GSH) is a ~307 Da tripeptide with the sequence γ-glutamyl-cysteinyl-glycine. The unusual γ-peptide bond between glutamate and cysteine (vs the typical α-peptide bond) protects glutathione from standard peptidase cleavage and gives the molecule its characteristic intracellular stability. The cysteine thiol group is the redox-active site — glutathione donates a hydrogen atom from this thiol to reactive oxygen species, becoming oxidised glutathione (GSSG) in the process.

Cellular glutathione is regenerated from GSSG by glutathione reductase, an NADPH-dependent enzyme. The ratio of reduced (GSH) to oxidised (GSSG) glutathione is a primary cellular indicator of redox state. The intracellular GSH:GSSG ratio is typically 100:1 or higher in healthy cells, reflecting strong reductive capacity.

Cellular functions

The published research consolidates glutathione’s cellular functions into four categories:

• Antioxidant defence. Direct scavenging of reactive oxygen species; substrate for glutathione peroxidase (which uses GSH to reduce hydrogen peroxide and lipid hydroperoxides).
• Phase-II conjugation detoxification. Substrate for glutathione S-transferases (GSTs), enzymes that conjugate glutathione to lipophilic toxins for excretion. The liver glutathione system is the primary detoxification pathway for many endogenous and exogenous compounds.
• Immune-cell function. T-cell proliferation, cytokine production, and lymphocyte function are glutathione-dependent. Intracellular glutathione depletion impairs adaptive immune function.
• Protein function and signalling. S-glutathionylation of cysteine residues on regulatory proteins is a reversible post-translational modification involved in redox signalling.

The bioavailability problem

The central practical challenge with exogenous glutathione supplementation is bioavailability. Glutathione does not cross cell membranes efficiently — cellular glutathione is mostly synthesised intracellularly from amino-acid precursors rather than imported intact. Exogenous supplementation faces three obstacles:

• Oral glutathione is largely hydrolysed by gut peptidases before absorption. The bioavailable fraction is small. Some studies show modest plasma glutathione elevation with oral supplementation; the intracellular effect is harder to demonstrate.
• IV glutathione raises plasma glutathione concentration directly but the cellular uptake is limited by a saturable transporter. Most clinic-administered IV glutathione is cleared by the liver within hours; the sustained intracellular benefit at typical IV doses is debated in the published literature.
• Topical glutathione has limited dermal penetration. Topical-formulation research has reported modest effects on melanin synthesis and skin appearance; systemic effects from topical delivery are minimal.

Honest take: the bioavailability problem is real and is the single biggest reason supplementation effect sizes are smaller than marketing claims suggest. Raising plasma glutathione is not the same as raising intracellular glutathione, and the cellular-level benefits are the ones that matter biologically.

UAE supplementation market

The UAE glutathione market is dominated by three product categories:

• IV glutathione protocols at longevity and wellness clinics. Dubai-based clinics offer IV infusions ranging from 600 mg to 5 g per session, sometimes combined with vitamin C or alpha-lipoic acid. Pricing is in the premium range (AED 500-2,500 per session); marketing emphasises detoxification, skin-brightening, and energy.
• Oral and sublingual supplements. Consumer supplement market includes reduced glutathione capsules, S-acetyl-glutathione (engineered for improved oral bioavailability), and sublingual formulations. Price ranges widely; bioavailability claims should be read carefully against the published evidence.
• Liposomal glutathione. Formulations encapsulating glutathione in phospholipid vesicles to improve oral absorption. Some published data supports modestly improved bioavailability vs unencapsulated oral; the effect-size improvement is real but smaller than premium pricing implies.

Research-grade supply

Research-grade glutathione is supplied as lyophilised powder for laboratory protocols. Wellness Labs catalogues research-grade glutathione for non-clinical investigation. The research-supply market is distinct from the consumer-supplement and IV-clinic markets; the research-grade specifications focus on HPLC purity and absence of oxidised glutathione contamination, vs the consumer-supplement market’s focus on capsule formulation and dosing.

Open research questions

• The intracellular bioavailability of IV glutathione at clinic-protocol doses. The pharmacokinetic data is reasonable; the intracellular pharmacodynamic data is thinner.
• Whether liposomal glutathione produces meaningfully greater intracellular effects than equivalent oral GSH or precursor-amino-acid (N-acetylcysteine) supplementation.
• Long-term safety of high-dose IV glutathione protocols. The acute safety profile is well-characterised; chronic-administration safety beyond months of repeated infusion is less thoroughly studied.

Further reading

• Glutathione delivery routes — IV vs oral vs liposomal.
• Glutathione mechanism deep-dive.
• Glutathione dosing in research and supplementation protocols.

Last reviewed 2 June 2026. Editorial inbox: info@uaewellnesslab.com.